Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
Wanaporn Charoenchokthavee,1 Duangchit Panomvana,1 Virote Sriuranpong,2 Nutthada Areepium1 1Department of Pharmacy Practice, Faculty of Pharmaceutical Science, 2Medical Oncology Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Background: Tamoxifen (TAM)...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/dd4638e7387d4ee68431b6537441d76d |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|